- Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. Cloughesy, T.F., Kuhn, J., Robins, H.I., Abrey, L., Wen, P., Fink, K., Lieberman, F.S., Mehta, M., Chang, S., Yung, A., DeAngelis, L., Schiff, D., Junck, L., Groves, M., Paquette, S., Wright, J., Lamborn, K., Sebti, S.M., Prados, M. J. Clin. Oncol. (2005)